Introduction N-Nitr<:>sodietha nolamine (NDELA*) is one of the most prevalent of the environmental N-nitroso compounds. It has been detected in exceptionally high concentrations, up to 3%, in industrial metal grinding fluids, and in the urine of metal grinders (1 ,2). It has been reported as a common contaminant of cosmetics and toiletries, and is found in tobacco and tobacco smoke (3, 4) . Nnitrosomorpholin e (NMOR) has been frequently detected, sometimes at high levels, in the air of rubber and lyremanufacturing factories (5) . It also has been found in cosmetics, toiletries and the fine-cut chewing tobacco used for snuff-dipping (3, 6) .
The hepatocarcinogen icities of NDELA and NMOR in the rat have been repeatedly confirmed, most recently in an extensive series of dose-response studies which demonstrated that NMOR is more potent than NDELA (7) (8) (9) (10) . NMOR is one of the most carcinogenic of the N-nitroso compounds which occur in the environment.
N-Nitroso-2-hydr oxymorpholine (NHMOR) has been detected as a metabolite of NDELA in rat liver 9000 g supernatant (II, 12).
In vivo, it is apparently oxidized to N-nitroso-2-hydr oxyethylglycine (NHEG), which is a urinary metabolite of NDELA (see Figure 1 ) (13, 14) . Up to 95% of NDELA administered per os
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to rats is excreted unchanged (14, 15) . The detection ofNHMOR as a metabolite of NDELA, and its mutagenicity in Salmonella typhimurium, with or without activation, suggested that it might be a proximate carcinogen of NDELA (12, 16) . Alcohol dehydrogenase activation of NDELA produced mutations in S.typhimurium, which is consistent with this hypothesis (17) . NHMOR also caused single-strand breaks in primary rat hepatocytes and in rat liver in vivo (16) . It reacted with deoxyguanosine to produce a cyclic I ,N 2 -glyoxal adduct (18) and transferred its nitroso group to secondary amines (11 ,19) .
In contrast to NDELA, NMOR is extensively metabolized in the rat, with onlf 1 -2 % of the dose being excreted unchanged in urine (20) . Established pathways of metabolism include a-hydroxylation, ,6-hydroxylation to NHMOR and NDELA, and denitrosation (20) (21) (22) (23) . Several lines of evidence favor a-hydroxylation of nitrosamines as an important metabolic activation mechanism (20, 24) , but the direct genotoxicity of NHMOR suggested that ,6-hydroxylation of NMOR may also be involved in activation of NMOR.
In the present study, we have evaluated the comparative tumorigenic activities of NDELA, NMOR and NHMOR in A/J mice and F344 rats in order to assess the possible role of NHMOR in carcinogenesis of NDELA and NMOR.
Materials and methods

Chemicals
NHMOR was synthesized and purified as previously described (12) . It was pure according to TLC and NMR analysis. NDELA and NMOR were also prepared and purified as described (10, 25, 26) .
Animals
Female A/J mice, age 8-10 weeks were obtained from Jackson Laboratories, Bar Harlx>r, ME. They were housed in groups of 10 in solid-bottom polycarbonate cages with hardwood bedding. The animals were kept at 20 :1:: 2°C and 50 :1:: 10% {SD) relative humidity with a 12 h light:dark cycle. They were given NIH.()7 diet ad libitum.
Female F344 rats, age 8 weeks, were born and raised in the Frederick Cancer Research Facility. They were maintained in cages of four within a barrier, and 14'
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Bioassay in All mice
The mice were assigned to groups as summarized in Table I . For the first 10 weeks of the bioassay, 0.2 pmol!ml nitrosamines were added to the drinking water. Fresh solutions of the nitrosamines in amber bottles were provided twice weekly. Water consumption was measured twice weekly during the I 0 weeks of nitrosamine treatment. After these 10 weeks were complete. animals received tap water for the next 20 weeks. They were then killed by C0 2 immersion, and lung adenomas were counted. Statistical significance was assessed by the i test and Student's t-test.
Bioassay in F344 rats
Rats were assigned to groups as indicated in Table II . Each cage of four rats was given 80 ml of the appropriate nitrosamine solution, or tap water alone for the control group, on each of 5 days per week. All of this was comsumed with little spillage. On the other 2 days, water was given ad libitum to allow the rats to make up any water deficiency that had been incurred. The treatments continued for 50 weeks, after which the animals were maintained until they died or were ~ killed when moribund. Survivors were killed at weeks 120-124. The animals were necropsied and all lesions, together with major organs and tissues. were fixed in formalin, embedded in paraffin, sectioned and stained for histologic exanunallon . Table II , NMOR at 26.5 mg/1 of water, correspon ding to a weekly dose of -23 J.tmol/rat, was by far the most carcinoge nic treatment , leading to death of half of the animals by week 64 and to death of all by week 73. All of these rats had neoplasms in the liver, hepatocel lular carcinoma s or hemangio sarcomas, often both, more than half of which metastasiz ed to the lungs. Incidence s of other neoplasms were small (Table III) and probably not related to the treatment. The NDELA treatment was less effective, although the molar dose delivered to the animals was five times that of NMOR. Half of the NDELA-t reated rats were dead at week 101 and the last two survivors were killed at week 120. More than half of them had liver neoplasms , all but one hepatocel lular and few of these had metastasiz ed. There were few other neoplasm s that were considered potentially treatment related in the group of rats given NDELA, but one was a tubular cell adenoma of the kidney.
Results
At week 100, most of the rats given NHMOR and most of the control rats were alive; ~20% in these groups survived until they were killed. No treatment-related neoplasm s were seen in the groups given NHMOR at either dose level. Tumors were present in most of these animals, but they are considere d spontaneo us in F344 rats and did not differ significan tly in incidence from the controls. They included neoplasm s of the pituitary, adrenal medulla, thyroid C-cells, mammary gland, pancreas islets and mononucl ear cell leukemia.
Discussio n
The results of this study do not support the hypothesi s that NHMOR is involved in the tumorigen ic metabolic activation of NDELA or NMOR. In mice and rats, NHMOR was either very weakly active or inactive at the doses tested, whereas NMOR was strongly tumorigenic in both species. These results indicate that NHMOR is a detoxified metabolite of NMOR. In rats, 40-60% of NMOR metabolism proceeds by this pathway, as determined by measuring levels of NHEG in urine (27) . (3-0x.idation of NDELA to NHMOR in vivo in the rat accounts for < 10% of the dose, based on excretion of NHEG in urine (13, 14, 27) . In the bioassay in rats, the higher dose of NHMOR was 20% of the dose of NDELA. Thus, if NHMOR were a proximate carcinogen of NDELA, one would have expected to see at least a comparable tumor yield from the two compounds. This was not observed, and there was no indication that NHMOR was carcinogenic in the rat. In mice, equivalent doses of NHMOR and NDELA gave similar weak responses, which also indicates that NHMOR is not a proximate tumorigen of NDELA in A/J mice. Previous studies have shown that NHMOR is an effective inducer of single-strand breaks in rat liver, and is mutagenic toward s. ophimurium with and without rat liver 9000 g supernatant activation (12, 16) . The mechanisms of single-strand breakage and mutagenicity by NHMOR are not known, but may be unrelated to carcinogenesis by this compound since no liver tumors were observed in the treated rats.
Sterzel and Eisenbrand have suggested that sulfation of NDELA may be an activation mechanism, since induction of single-strand breaks was abolished by a sulfotransferase inhibitor (28) . NDELA sulfate could cause 2-hydroxyethylatio n of DNA according to the mechanism proposed by Michejda and coworkers (29) . Support for this mechanism has been obtained by the tentative identification of2-hydroxyethyl adducts in liver DNA of NDELA-treated rats (14) . Further studies are required to determine whether this, or other activation mechanisms, are involved in the expression of NDELA carcinogenicity.
